An approval by the US Food and Drug Administration later this month for Protalix/Pfizer's plant-derived human therapeutic protein taliglucerase alfa would mark a first for 'pharmers'.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Opar, A. 'Pharmers' hope for first plant drug harvest. Nat Rev Drug Discov 10, 81–82 (2011). https://doi.org/10.1038/nrd3369
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrd3369
This article is cited by
-
Production and Purification of Recombinant Glucocerebrosidase in Transgenic Rice Cell Suspension Cultures
Applied Biochemistry and Biotechnology (2017)
-
Current state and recent advances in biopharmaceutical production in Escherichia coli, yeasts and mammalian cells
Journal of Industrial Microbiology and Biotechnology (2013)